Psychotropic Treatment Pattern in Medicaid Pediatric Patients With Concomitant ADHD and ODD/CD

J Atten Disord. 2019 Jan;23(2):140-148. doi: 10.1177/1087054715596574. Epub 2015 Aug 12.

Abstract

Objective: To describe psychotropic treatment pattern and evaluate the association of socio-demographic factors and psychotropic combination therapy in children with ADHD and oppositional defiant disorder/conduct disorder (ODD/CD).

Method: This is a cross-sectional drug utilization study based on Medicaid fee-for-service programs in 26 U.S. states (1999-2006). Children aged 4 to 18 with concomitant ADHD and ODD/CD were included. We calculated the prevalence of psychotropic drugs and used logistic regression to evaluate the role of socio-demographic factors in psychotropic combination therapy.

Results: We identified 121,740 children with ADHD and ODD/CD (140,777 person-years). The period prevalence of "no psychotropic therapy," psychotropic monotherapy, and psychotropic dual therapy was 38.1%, 44.7%, and 9.0%, respectively. The most common drug class was stimulants. Whites, males, and children in foster care were more likely to use psychotropic combination therapy. State-level variation was observed.

Conclusion: "No psychotropic therapy" and stimulants dominate treatment choices in children with ADHD and ODD/CD. Socio-demographic characteristics are associated with combination psychotropic therapy.

Keywords: ADHD; Medicaid; conduct disorder; oppositional defiant disorder; psychotropic drugs.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Attention Deficit Disorder with Hyperactivity / drug therapy*
  • Attention Deficit Disorder with Hyperactivity / epidemiology
  • Attention Deficit and Disruptive Behavior Disorders / complications
  • Attention Deficit and Disruptive Behavior Disorders / drug therapy*
  • Central Nervous System Stimulants / therapeutic use
  • Child
  • Child, Preschool
  • Combined Modality Therapy
  • Conduct Disorder / drug therapy*
  • Conduct Disorder / epidemiology
  • Cross-Sectional Studies
  • Drug Utilization
  • Female
  • Humans
  • Male
  • Medicaid / statistics & numerical data*
  • Prevalence
  • Psychotropic Drugs / therapeutic use*
  • United States

Substances

  • Central Nervous System Stimulants
  • Psychotropic Drugs